Marlap

Obsidian Therapeutics Inc, based in Cambridge, MA, is at the forefront of precision cell and gene therapy, utilizing its proprietary cytoDRIVE platform to engineer regulated therapeutic proteins. The company is dedicated to pioneering the next generation of engineered therapeutics to address critical patient needs. With a focus on innovative solutions, Obsidian is advancing its lead clinical program, OBX115, an engineered TIL cell therapy targeting advanced melanoma. The company’s commitment to collaboration and urgency drives its mission to improve patient outcomes through cutting-edge science and technology. Generated from the website

Boston Biochem, now part of R D Systems, offers top-quality research products related to the Ubiquitin Proteasome System (UPS). Their range includes bioactive E3 ligases, Ubiquitin, DUBs, E1s, E2s, and more, catering to researchers in need of reliable tools for UPS-related studies. Generated from their website's infomation